Hosted on MSN1mon
Goldman Sachs Initiates Coverage of Silence Therapeutics plc - Depositary Receipt () (SLN) with Sell RecommendationF intel reports that on February 11, 2025, Goldman Sachs initiated coverage of Silence Therapeutics plc - Depositary Receipt (NasdaqGM:SLN) with a Sell recommendation. Analyst Price Forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback